Almac Group Appoints Three Vice Presidents

Craigavon, N.I., 25 July 2018 –  Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced the appointment of three new Vice Presidents within its Pharma Services Business Unit as it expands its executive team.

Jonas Mortensen is appointed to the position of Vice President of Business Development. Bringing extensive experience to the role, Jonas is responsible for leading the global Business Development, Proposal and Marketing teams. Jonas is a graduate of the University of Copenhagen with a Masters in Biology. He started his career in discovery research as a scientist and project management before progressing into quality management for a Scandinavian pharmaceutical products company and until recently, worked in Business Development for a leading CDMO.

 

Grainne Hughes, who joined Almac Pharma Services in 1999 and in most recent years held the position of Head of Operations, was promoted to Vice President of Business Support Operations. Grainne will lead all support functions across the business including Client Services, Planning, Business Systems and Business Projects. Grainne graduated from Queen’s University Belfast with a BSc in Biomedical Sciences and also obtained an MSc in Manufacturing Management from Ulster University.

 

In a similar move, Mark English, who joined Almac Pharma Services in 2010 as Distribution Manager and in most recent years was Head of Logistics, has now been promoted to the position of Vice President of Packaging & Logistics Operations. In this role, Mark will have responsibility for all packaging and logistic operations across Almac Pharma Services’ global commercial facilities in the UK, Ireland and USA. Mark is a graduate of the University of Edinburgh and holds a BEng in Chemical Engineering.

 

Graeme McBurney, President and Managing Director of Almac Pharma Services commented “We are delighted to welcome Jonas, Grainne and Mark to their new positions at Almac Pharma Services. They each bring a wealth of experience and impressive track records in their various roles. We look forward to their contribution to the delivery and success of our future expansion plans.”

###

About Almac Group 
‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has organically grown over almost 50 years and now employs close to 5600 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo). To keep up to date with our latest news, follow us on Twitter and LinkedIn.